Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes

• Theone C. Kon ,

  * E-mail: theone.kon@intravacc.nl

  Affiliation Department of Product Development, Intravacc, Institute for Translational Vaccinology, Bilthoven, The Netherlands

  ⨯
• Adrian Onu,

  Affiliation Laboratory of Biotechnology, Cantacuzino National Research Institute, Bucharest, Romania

  ⨯
• Laurentiu Berbecila,

  Affiliation Unit of Influenza Vaccine Production, Cantacuzino National Research Institute, Bucharest, Romania

  ⨯
• Emilia Lupulescu,

  Affiliation Laboratory of Respiratory Viral Infections, Cantacuzino National Research Institute, Bucharest, Romania

  ⨯
• Alina Ghiorgisor,

  Affiliation Laboratory of Respiratory Viral Infections, Cantacuzino National Research Institute, Bucharest, Romania

  ⨯
• Gideon F. Kersten,

  Affiliation Department of Research, Intravacc, Institute for Translational Vaccinology, Bilthoven, The Netherlands

  ⨯
• Yi-Qing Cui,

  Affiliation Department of Product Development, Intravacc, Institute for Translational Vaccinology, Bilthoven, The Netherlands

  ⨯
• Jean-Pierre Amorij ,

  ¶‡ These authors are shared last authors on this work.

  Affiliation Department of Business Development, Intravacc, Institute for Translational Vaccinology, Bilthoven, The Netherlands

  ⨯
• Leo Van der Pol

  ¶‡ These authors are shared last authors on this work.

  Affiliation Department of Research, Intravacc, Institute for Translational Vaccinology, Bilthoven, The Netherlands

  ⨯